Massachusetts BCBS to limit painkiller scripts; Amgen wraps up Turkish generics buy;

@FiercePharma: Here's an offbeat pharma story: Sanofi's investor relations team won the prize in a Thomson Reuters financial contest--Reuters. Report | Follow @FiercePharma

> Massachusetts' biggest insurer plans to restrict painkiller prescriptions to 30-day supplies in an attempt to curb abuse of narcotics such as OxyContin. Report

> U.S.-based Upsher-Smith Laboratories has agreed to buy drug developer Proximagen for $347 million plus potential future payments of up to $208 million. Story

> Amgen ($AMGN) wrapped up its $700 million acquisition of the Turkish genericsmaker Mustafa Nevzat Pharmaceuticals. More

> Jazz Pharmaceuticals ($JAZZ) closed its buyout of EUSA Pharma in a $680 million deal, expecting the acquisition to add to earnings this year. News

> The FDA proposes to add warnings to the labels of drugs manufactured with albumin, cautioning of an "extremely remote risk" of transmission of viral diseases. Article

> U.K. regulators plan to add "youth friendly" language to the patient information that accompanies ADHD drugs. Report

Biotech News

@FierceBiotech: The ethics of finding markers in a fetal genome. Story | Follow @FierceBiotech

@JohnCFierce: Novartis is going to invest $700M in Malaysian biotechs? Really? Report | Follow @JohnCFierce

@RyanMFierce: Sequoia-backed startup enters race to make sense of the genome. Article | Follow @RyanMFierce

> Upsher-Smith embraces biotech with $553M deal to buy Proximagen. News

> Rhythm banks $25M for mid-stage work on diabetes, obesity drugs. Story

> Merck preps FDA app after racking up positive PhIIIs on new sleep drug. Article

Medical Devices News

@FierceMedDev: Advanced diagnostic imaging use has grown drastically, boosting radiation exposure risks, a new JAMA study concludes. News | Follow @FierceMedDev

@MarkHFierce: Seventh Sense Biosystems raises $10M Series A and brings on a new CEO to help develop its blood sampling system. Release | Follow @MarkHFierce

> CMS to pare back Medicare coverage for low back pain treatment-devices. More

> Brigham Young engineers create next-gen spinal disc implant. Story

> St. Jude stock nosedives after reported Durata lead flaw. News

Drug Delivery News

@DamianFierce: One U.K. company is developing a chocolate-based drug delivery platform, and NIH has taken notice. Story | Follow @DamianFierce

> Zogenix signs co-promotion deal for needle-free migraine treatment. More

> Allergan looks to needle-free delivery for Botox. More

> J&J moves forward with next-gen insulin delivery. Item

Biomarkers News

> Cluster of genes is biomarker for breast cancer recurrence. Story

> Methylation marker tags leukemia outcomes. Article

> Gene signatures tag breast cancer drug response. News

> Scientists detect Down syndrome using mother's blood. More

And Finally... A Pulitzer Prize winner's long view on healthcare, innovation and aging. Report